Eureka Forbes Q1 Results FY26: Q1 PAT Rises 20.32% to ₹38.68 Crore; Revenue Up 9.85% YoY

Eureka Forbes Q1 Results FY26: Eureka Forbes posted its Q1 results on 11th August 2025. The company posted robust numbers, with Q1 PAT standing at ₹38.68 crores against revenue of ₹607.87 crores. During Q1 FY26, the profit increase of the company was recorded at 20.32% YoY, and the revenue increase for the same period was 9.85%. 

Eureka Forbes Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

(Figures in crores)

Eureka Forbes Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

(Figures in crores)

Eureka Forbes Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• Eureka Forbes clocked Q1 FY26 consolidated revenue of ₹607.87 crores vs ₹553.38 crores. 
• On the profit front, Eureka Forbes earned a consolidated PAT of ₹38.68 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹32.15 crore. 
• Consolidated PAT rose for the first quarter of FY26, was 20.32% YoY, and revenue rose 9.85% YoY. 
• As per the standalone figures, the quarterly PAT of Eureka Forbes has increased by 24.11%, and revenue has increased by 9.94% YoY.

Eureka Forbes Share Price Performance

On the opening bell of 11th August 2025, the shares of Eureka Forbes opened at ₹560.00 per share. However, the initial gains are wiped out as of now, and Eureka Forbes shares are trading at ₹552.80 per share, higher than their opening price. 

Considering the long-term performance, Eureka Forbes shares have yielded close to 9.24% returns in the past 1 year, and 5-year returns stand at 2.14%. Over the maximum timeframe, the Eureka Forbes share provided 2.14% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Eureka Forbes shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates

Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates

Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?

Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY

Action Construction Equipment Q1 Results FY26: Q1 PAT Rises 16.08% to ₹97.72 Crore; Revenue Down 11.19% YoY

Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More

JSW Cement IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Mahendra Realtors IPO GMP & Review: Apply or Avoid?

Regaal Resources IPO GMP & Review: Apply or Avoid?

Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?